Glucagon receptor activation is what makes retatrutide genuinely novel
If you have been on 15mg for at least 12 weeks and have lost less than 5% of your starting body weight despite good dietary compliance and regular exercise, that suggests non-response rather than a simple plateau
Feinglos for discussion of the in vivo results
Cardiovascular benefits: Semaglutide has shown significant cardiovascular risk reduction, including decreased risk of major adverse cardiovascular events (MACE) and stroke
There is no excuse for prescribing diuretics before CHF because no unwanted fluids are being retained in the dog's heart or lungs until heart failure starts
Why GLP-1 drugs and menopause could create a perfect storm for bone loss Bone loss can lead to osteoporosis, which causes bones to become porous, weaker and brittle, making them more likely to break, often in the hips, spine and wrists